Cargando…
Targeted treatments for fragile X syndrome
Fragile X syndrome (FXS) is the most common identifiable genetic cause of intellectual disability and autistic spectrum disorders (ASD), with up to 50% of males and some females with FXS meeting criteria for ASD. Autistic features are present in a very high percent of individuals with FXS, even thos...
Autores principales: | Berry-Kravis, Elizabeth, Knox, Andrew, Hervey, Crystal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261278/ https://www.ncbi.nlm.nih.gov/pubmed/21484200 http://dx.doi.org/10.1007/s11689-011-9074-7 |
Ejemplares similares
-
Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2012) -
Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
por: Knox, Andrew, et al.
Publicado: (2012) -
Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome
por: Farzin, Faraz, et al.
Publicado: (2011) -
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018) -
Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)